paper-with-me

Papers

Scaffold-constrained molecular generation

2020-09-15 · Maxime Langevin, Herve Minoux, Maximilien Levesque, Marc Bianciotto

One of the major applications of generative models for drug Discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de-novo drug design. To tackle this issue, we introduce a new algorithm to perform scaffold-constrained in-silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement Learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and, finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.

📄 PDF Abstract BibTeX arXiv:2009.07778

Code (0)

등록된 구현이 없습니다.

Tasks

Drug DesignDrug Discovery

Similar Papers 제목 키워드 기반

Scaffold-Conditioned Preference Triplets for Controllable Molecular Optimization with Large Language Models

2026-04-14 · Yi Xiong, Liang Xiong, Xiaohong Ji, Sen Yang 외 arxiv

Molecular property optimization is central to drug discovery, yet many deep learning methods rely on black-box scoring and offer limited control over scaffold preservation, often producing unstable or biologically implau…

Drug Discovery

MADGEN: Mass-Spec attends to De Novo Molecular generation

2025-01-03 · Yinkai Wang, Xiaohui Chen, LiPing Liu, Soha Hassoun

The annotation (assigning structural chemical identities) of MS/MS spectra remains a significant challenge due to the enormous molecular diversity in biological samples and the limited scope of reference databases. Curre…

Contrastive LearningDe novo molecule generation from MS/MS spectrumDe novo molecule generation from MS/MS spectrum (bonus chemical formulae)+1

Learning to Extend Molecular Scaffolds with Structural Motifs

2021-03-05 · ICLR 2022 4 · Krzysztof Maziarz, Henry Jackson-Flux, Pashmina Cameron, Finton Sirockin 외

Recent advancements in deep learning-based modeling of molecules promise to accelerate in silico drug discovery. A plethora of generative models is available, building molecules either atom-by-atom and bond-by-bond or fr…

Drug Discovery

Gotta be SAFE: A New Framework for Molecular Design

2023-10-16 · Emmanuel Noutahi, Cristian Gabellini, Michael Craig, Jonathan S. C Lim 외

Traditional molecular string representations, such as SMILES, often pose challenges for AI-driven molecular design due to their non-sequential depiction of molecular substructures. To address this issue, we introduce Seq…

DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning

2019-08-20 · Yibo Li, Jianxing Hu, Yanxing Wang, Jielong Zhou 외

The ultimate goal of drug design is to find novel compounds with desirable pharmacological properties. Designing molecules retaining particular scaffolds as the core structures of the molecules is one of the efficient wa…

Drug DesignDrug DiscoveryMolecular Docking